Description  Claims  Cited references 

Crystal Deposition Diseases   [0002] 
Lancet   [0002] 
Solute carrier family 2, member 9 and uric acid homeostasis   [0007] 
Uric acid transport and disease   [0008] 
Developing potent human uric acid transporter 1 (hURAT1) inhibitors   [0008] 
Benzbromarone withdrawn from the European market: another case of ''absence of evidence is evidence of absence   [0009] 
Sequential metabolism and bioactivation of the hepatotoxin benzbromarone: formation of glutathione adducts from a catechol intermediate   [0010] 
Roles of rat renal organic anion transporters in transporting perfluorinated carboxylates with different chain lengths   [0142]